Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations

SOX1 autoantibodies are considered markers of small cell lung cancer (SCLC) and paraneoplastic neurological syndromes (PNS) and are usually determined by commercial line blot in many clinical services. Recent studies suggested that SOX1 autoantibodies also occur in patients with neuropathies unrelat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Ruiz-García, Raquel, Martínez-Hernández, Eugenia, García-Ormaechea, Milagros, Español-Rego, Marta, Sabater, Lidia, Querol, Luis, Illa, Isabel, Dalmau, Josep, Graus, Francesc
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473043/
https://ncbi.nlm.nih.gov/pubmed/31031763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00769
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki